PANAGORA ASSET MANAGEMENT INC

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 883677 Boston, MA

Position in LXRX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$316,900

+$205,813 QoQ

Shares Held

132,042

+148.4% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#48

of 148 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. LXRX ranks #71 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$316,900	132,042	+148.4%	Shares	Sole	2026-08-06
2022-03-31	$111,087	53,152	-81.6%	Shares	Sole	2022-05-12
2021-12-31	$1,140,547	289,479	+0.1%	Shares	Sole	2022-02-10
2021-09-30	$1,390,830	289,154	+5.6%	Shares	Sole	2021-11-10
2021-06-30	$1,256,439	273,734	+59.3%	Shares	Sole	2021-08-11
2021-03-31	$1,008,894	171,873	+4.8%	Shares	Sole	2021-05-12
2020-12-31	$561,054	164,051	+0.3%	Shares	Sole	2021-02-10
2020-09-30	$235,550	163,577	+197.4%	Shares	Sole	2020-11-13
2020-06-30	$110,006	55,003	-57.7%	Shares	Sole	2020-08-12
2020-03-31	$253,737	130,122	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.